Iovance Biotherapeutics (NASDAQ:IOVA) saw significant upgrades in revenue forecasts, with analysts predicting a 396% increase by 2024. Share price surged 36% in 7 days. Analysts expect accelerated growth, reduced losses, and profitability in the near future.